ProNoxis Overview
- Year Founded
-
2009
- Status
-
Acquired/Merged
- Employees
-
2
- Latest Deal Type
-
M&A
ProNoxis General Information
Description
Developer and researcher of medical treatments intended to focus on the preclinical discovery of small-molecule drugs to treat chronic inflammation, autoimmunity, and infections. The company's service offerings include developing anti-inflammatory therapeutics targeting the activation of the NADPH oxidase complex (NOX2).
Contact Information
Website
www.pronoxis.com(Operating Subsidiary)
Corporate Office
- Lund Life Science Incubator
- Medicon Village
- 223 81 Lund
- Sweden
Corporate Office
- Lund Life Science Incubator
- Medicon Village
- 223 81 Lund
- Sweden
ProNoxis Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 26-Nov-2012 | Completed | Generating Revenue | |||
| 5. Early Stage VC | 17-Jun-2011 | Completed | Startup | |||
| 4. Early Stage VC | Completed | Startup | ||||
| 3. Early Stage VC | Completed | Startup | ||||
| 2. Early Stage VC | Completed | Startup | ||||
| 1. Early Stage VC | 01-Jan-2009 | Completed | Startup |
ProNoxis Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
ProNoxis Patents
ProNoxis Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-201216381-D0 | New compounds and medical uses | Inactive | 13-Sep-2012 | ||
| GB-201208970-D0 | New compounds and medical uses | Inactive | 22-May-2012 | ||
| GB-201104875-D0 | New compounds and medical uses | Inactive | 23-Mar-2011 | ||
| GB-201104872-D0 | New compounds and medical uses | Inactive | 23-Mar-2011 | ||
| GB-201104600-D0 | New compounds and medical uses | Inactive | 18-Mar-2011 | A61K31/4741 |
ProNoxis Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
ProNoxis Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Karolinska Development | Venture Capital | Minority | ||
| Lund University Bioscience | Venture Capital | Minority |
ProNoxis FAQs
-
When was ProNoxis founded?
ProNoxis was founded in 2009.
-
Where is ProNoxis headquartered?
ProNoxis is headquartered in Lund, Sweden.
-
What is the size of ProNoxis?
ProNoxis has 2 total employees.
-
What industry is ProNoxis in?
ProNoxis’s primary industry is Drug Discovery.
-
Is ProNoxis a private or public company?
ProNoxis is a Private company.
-
What is ProNoxis’s current revenue?
The current revenue for ProNoxis is .
-
How much funding has ProNoxis raised over time?
ProNoxis has raised $637K.
-
Who are ProNoxis’s investors?
Karolinska Development and Lund University Bioscience have invested in ProNoxis.
-
When was ProNoxis acquired?
ProNoxis was acquired on 26-Nov-2012.
-
Who acquired ProNoxis?
ProNoxis was acquired by Redoxis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
